MAPK1 and chronic obstructive pulmonary disease: The limited efficacy of corticosteroids in alleviating the chronic inflammation of human bronchial epithelial cells in asthma and COPD after an oxidative stress challenge has raised more attention to developing effective p38 inhibitors [62].